| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |